These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29061953)

  • 1. Efficacy of Antiviral Drugs against Feline Immunodeficiency Virus.
    Hartmann K; Wooding A; Bergmann M
    Vet Sci; 2015 Dec; 2(4):456-476. PubMed ID: 29061953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of antiviral chemotherapy for retrovirus-infected cats: What does the current literature tell us?
    Hartmann K
    J Feline Med Surg; 2015 Nov; 17(11):925-39. PubMed ID: 26486979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.
    Medinas RJ; Lambert DM; Tompkins WA
    J Virol; 2002 Sep; 76(18):9079-86. PubMed ID: 12186891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologic disease in feline immunodeficiency virus infection: disease mechanisms and therapeutic interventions for NeuroAIDS.
    Power C
    J Neurovirol; 2018 Apr; 24(2):220-228. PubMed ID: 29247305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of incidental infections and immune activation on disease progression in experimentally feline immunodeficiency virus-infected cats.
    Reubel GH; Dean GA; George JW; Barlough JE; Pedersen NC
    J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1003-15. PubMed ID: 7916048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of in vivo and in vitro interactions of feline immunodeficiency virus and feline leukemia virus.
    Beebe AM; Faith TG; Sparger EE; Torten M; Pedersen NC; Dandekar S
    AIDS; 1994 Jul; 8(7):873-8. PubMed ID: 7946095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feline immunodeficiency virus infection.
    Pedersen NC; Yamamoto JK; Ishida T; Hansen H
    Vet Immunol Immunopathol; 1989 May; 21(1):111-29. PubMed ID: 2549690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro characterization of FIV-pPPR, a pathogenic molecular clone of feline immunodeficiency virus, and two drug-resistant pol gene mutants.
    McCrackin Stevenson MA; McBroom DG
    Am J Vet Res; 2001 Apr; 62(4):588-94. PubMed ID: 11327469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Looking for Novel Capsid Protein Multimerization Inhibitors of Feline Immunodeficiency Virus.
    Sierra N; Folio C; Robert X; Long M; Guillon C; Álvarez G
    Pharmaceuticals (Basel); 2018 Jul; 11(3):. PubMed ID: 29996481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal immunodeficiency viruses.
    Egberink H; Horzinek MC
    Vet Microbiol; 1992 Nov; 33(1-4):311-31. PubMed ID: 1336243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction.
    Beatty JA; Willett BJ; Gault EA; Jarrett O
    J Virol; 1996 Sep; 70(9):6199-206. PubMed ID: 8709246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced provirus burden and enhanced humoral immune function in AZT-treated SCID-feline mice inoculated with feline immunodeficiency virus.
    Johnson CM; Selleseth DW; Ellis MN; Childers TA; Tompkins MB; Tompkins WA
    Vet Immunol Immunopathol; 1995 May; 46(1-2):169-80. PubMed ID: 7618256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection.
    Pedersen NC; Torten M; Rideout B; Sparger E; Tonachini T; Luciw PA; Ackley C; Levy N; Yamamoto J
    J Virol; 1990 Feb; 64(2):598-606. PubMed ID: 2153226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma.
    Tanabe T; Yamamoto JK
    J Interferon Cytokine Res; 2001 Dec; 21(12):1039-46. PubMed ID: 11798461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for CD8+ antiviral activity in cats infected with feline immunodeficiency virus.
    Jeng CR; English RV; Childers T; Tompkins MB; Tompkins WA
    J Virol; 1996 Apr; 70(4):2474-80. PubMed ID: 8642675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
    Auwerx J; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired T-cell priming and proliferation in cats infected with feline immunodeficiency virus.
    Bishop SA; Williams NA; Gruffydd-Jones TJ; Harbour DA; Stokes CR
    AIDS; 1992 Mar; 6(3):287-93. PubMed ID: 1348945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents.
    Gardner MB
    Antiviral Res; 1991 May; 15(4):267-86. PubMed ID: 1659310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genome of feline immunodeficiency virus.
    Miyazawa T; Tomonaga K; Kawaguchi Y; Mikami T
    Arch Virol; 1994; 134(3-4):221-34. PubMed ID: 8129613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current thoughts on feline immunodeficiency virus infection.
    Sparger EE
    Vet Clin North Am Small Anim Pract; 1993 Jan; 23(1):173-91. PubMed ID: 8380656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.